Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer

Journal of Clinical Oncology- United States

doi 10.1200/jco.2011.39.8446

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society of Clinical Oncology (ASCO)

Related search

Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Dual Blockade With AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy--Dafne (GBG-70)

Clinical Cancer Research
Cancer ResearchOncology
2015English

Clinical and Immunological Assessment in Breast Cancer Patients Receiving Anticancer Therapy and Bovine Dialyzable Leukocyte Extract as an Adjuvant

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2010English

Primary Systemic Therapy for Operable Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1991English

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

New England Journal of Medicine
Medicine
2005English

Polymorphisms in AURKA and AURKB Are Associated With the Survival of Triple-Negative Breast Cancer Patients Treated With Taxane-Based Adjuvant Chemotherapy

Cancer Management and Research
Oncology
2018English

Replication of Genetic Polymorphisms Reported to Be Associated With Taxane-Related Sensory Neuropathy in Patients With Early Breast Cancer Treated With Paclitaxel--Response

Clinical Cancer Research
Cancer ResearchOncology
2015English

KIBRA; A Novel Biomarker Predicting Recurrence Free Survival of Breast Cancer Patients Receiving Adjuvant Therapy

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Benefits of Hyperthermia in Patients Receiving Radiation Therapy for Breast Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy